Anti-SSA/Ro are the most commonly seen in autoimmune diseases, such as systemic lupus erythematosus (SLE), Sjögren’s syndrome/SLE overlap syndrome, subacute cutaneous lupus erythematosus, neonatal lupus, and primary biliary cirrhosis [40]. Here, CALR is linked to neonatal lupus erythematosus.